|
Issue |
Title |
|
Vol 2, No 1 (2018) |
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 gene in child from Russia |
Abstract
PDF (Rus)
|
Kristina S. Kulikova, Eugeny V. Vasiliev, Vasily M. Petrov, Anatoly N. Tiulpakov |
|
Vol 1, No 1 (2017) |
Genotype-based personalized correction of glycemic control in patients with MODY due to mutations in GCK, HNF1A AND HNF4A genes |
Abstract
PDF (Rus)
|
Natalia A. Zubkova, Olesya A. Gioeva, Yulia V. Tikhonovich, Vasily M. Petrov, Evgeny V. Vasiliev, Anatoliy N. Tyulpakov, Ivan I. Dedov |
|
Vol 1, No 1 (2017) |
Perspectives of pharmacogenetics approach to personalized tamoxifen therapy |
Abstract
PDF (Rus)
|
Marina I. Savelyeva, Julia S. Panchenko, Irina A. Urvantseva, Anna K. Ignatova, Irina V. Poddubnaya |
|
Vol 1, No 1 (2017) |
Pharmacodynamic gene polymorphism and adverse drug reactionsthen applying antipsychotic drugs |
Abstract
PDF (Rus)
|
Mikhail S. Zastrozhin, Dmitry A. Sychev, Elena A. Grishina, Ludmila M. Savchenko, Evgeny A. Bryun |
|
Vol 1, No 1 (2017) |
Pharmacogenetic evaluation of adverse events’ risk in patients with alcohol withdrawal syndrome taking bromdihydrochlorphenylbenzodiazepine: The role of CYP2C19 gene polymorphisms |
Abstract
PDF (Rus)
|
Dmitriy V. Ivashchenko, Kristina A. Ryzhykova, Zhannet A. Sozaeva, Mikhail S. Zastrozhin, Elena A. Grishina, Lyudmila M. Savchenko, Eugeniy A. Bryun, Dmitriy A. Sychev |
|
Vol 1, No 1 (2017) |
Stages of development and implementation of personalized medicine technologies in clinical practice |
Abstract
PDF (Rus)
|
Dmitriy A. Sychev |
|
Vol 1, No 1 (2017) |
The personalized approach to neonatal diabetes therapy depending on the genetic defect |
Abstract
PDF (Rus)
|
Yulia V. Tikhonovich, Natalia A. Zubkova, Anatoly N. Tiulpakov |
|
Vol 1, No 1 (2017) |
The prospect of pluripotent stem cells for diabetes mellitus treatment |
Abstract
PDF (Rus)
|
Alexandra V. Panova, Daria V. Goliudsova, Sergey L. Kiselev |
|
1 - 8 of 8 Items |
|